title: [News on psoriasis from the 2010 Dermatology Days in Paris].
authors.affiliation: Service de dermatologie, hôpital La Grave, place Lange, Toulouse cedex 9, France. boulinguez.s@chu-toulouse.fr
authors.forename: Serge
authors.initials: S
authors.lastname: Boulinguez
mesh_terms: D017255:Acitretin / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D016572:Cyclosporine / Q000008:administration & dosage; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003880:Dermatology / Q000639:trends; D004359:Drug Therapy, Combination; D000068800:Etanercept; D019317:Evidence-Based Medicine; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D016896:Treatment Outcome; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D016572:Cyclosporine; D000069549:Ustekinumab; D017255:Acitretin; D000068800:Etanercept; D008727:Methotrexate